RYTNX | UOPSX | RYTNX / UOPSX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 25 years | 27 years | - |
Gain YTD | 49.121 | 43.714 | 112% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 15000 | 17% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 225M | 1.07B | 21% |
Annual Yield % from dividends | 0.12 | 0.00 | - |
Returns for 1 year | 72.82 | 66.86 | 109% |
Returns for 3 years | 32.76 | 2.31 | 1,420% |
Returns for 5 years | 160.73 | 132.86 | 121% |
Returns for 10 years | 413.31 | 546.97 | 76% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
TPLC | 45.60 | 0.29 | +0.65% |
Timothy Plan US Large/Mid Cap Core ETF | |||
SPYV | 54.33 | 0.19 | +0.35% |
SPDR® Portfolio S&P 500 Value ETF | |||
EPS | 62.97 | 0.15 | +0.24% |
WisdomTree US Earnings 500 ETF | |||
BBP | 67.70 | -0.45 | -0.66% |
Virtus LifeSci Biotech Products ETF | |||
RAAX | 29.67 | -0.29 | -0.97% |
VanEck Inflation Allocation ETF |